ClinVar Miner

Submissions for variant NM_001351132.2(PEX5):c.1381T>A (p.Ser461Thr)

gnomAD frequency: 0.00006  dbSNP: rs369698308
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001873121 SCV002140572 uncertain significance Peroxisome biogenesis disorder 2B 2022-09-01 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 461 of the PEX5 protein (p.Ser461Thr). This variant is present in population databases (rs369698308, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with PEX5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1372623). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002551152 SCV003712690 uncertain significance Inborn genetic diseases 2022-07-12 criteria provided, single submitter clinical testing The c.1381T>A (p.S461T) alteration is located in exon 13 (coding exon 12) of the PEX5 gene. This alteration results from a T to A substitution at nucleotide position 1381, causing the serine (S) at amino acid position 461 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV004749758 SCV005363236 uncertain significance PEX5-related disorder 2024-07-31 no assertion criteria provided clinical testing The PEX5 c.1381T>A variant is predicted to result in the amino acid substitution p.Ser461Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.013% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.